Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gestodene/Ethinylestradiol for Quality of Life in Menacme
NCT01174524Phase 4Completed
- Sponsor
- Hospital Geral de Fortaleza
- Start
- Jan 2008
- Primary completion
- Nov 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of gestodene and ethinyl estradiol in contraception, sponsored by Hospital Geral de Fortaleza. Primary endpoint: Quality of life at 11 months. Started Jan 2008; status: completed.
02
Drugs
gestodeneethinyl estradiol
03
Conditions
contraception
Beyond the preview
Go deeper on NCT01174524.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01174524.